Marcella Visentini


Titolo Pubblicato in Anno
Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients GASTROENTEROLOGY 2018
Switched CD21–/low B cells with an antigen-presenting phenotype in the infant thymus JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2018
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis CLINICAL RHEUMATOLOGY 2017
Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia. BLOOD 2017
From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals? EXPERT REVIEW OF HEMATOLOGY 2017
Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy Reply HEPATOLOGY 2017
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia HEPATOLOGY 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection BLOOD 2016
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy. HEPATOLOGY 2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review AUTOIMMUNITY REVIEWS 2015
Intravenous Immunoglobulin and Immunomodulation of B-Cell - in vitro and in vivo Effects FRONTIERS IN IMMUNOLOGY 2015
Editorial: Immunoglobulin therapy in the 21st century - The dark side of the moon FRONTIERS IN IMMUNOLOGY 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma